ERBB2 and hydrops fetalis: Notably, the HER-2/ErbB2 pathway also has an important effect on the pathogenesis of anthracycline-induced cardiotoxicity, which may explain the significantly higher rate of HF in patients treated with both anthracyclines and HER-2(/ErbB2) signaling pathway inhibitors [21,46].